Kyntra Bio, Inc. (0IL8.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 35.01M |
| Enterprise Value | 6.7M |
| P/E Ratio | 0.13 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 6.59 |
| Price/Book Ratio | -1.01 |
| Enterprise/Revenue | -4.38 |
| Enterprise/EBITDA | 0.21 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 39.68 |
| Operating Margin | -11.01 |
AD
Management Effectiveness
| Return On Assets | 1.81 |
| Return On Equity | -8.47 |
Income Statement
| Revenue | 6.44M |
| Revenue/Share | 1.14 |
| Gross Profit | 5.14M |
| EBITDA | -44.59M |
| Net Income | 130.9M |
| Diluted EPS | 45.36 |
Balance Sheet
| Total Cash | 91.32M |
| Total Cash/Share | 22.56 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 2.69 |
| Book Value Per Share | -2.01 |
Price History
| 52-Week Change | -34.66 |
| 52-Week High | 20.8 |
| 52-Week Low | 0.34 |
| Moving Average 50 Days | 1.58 |
| Moving Average 200 Days | 2.79 |
Statistics
| Average Volume | 28,076 |
| Shares Outstanding | 4.05M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | June 17, 2025 |
AD
